Compare PRPL & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRPL | STIM |
|---|---|---|
| Founded | 2010 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.8M | 105.5M |
| IPO Year | N/A | 2018 |
| Metric | PRPL | STIM |
|---|---|---|
| Price | $0.74 | $1.39 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $1.00 | ★ $7.00 |
| AVG Volume (30 Days) | 223.4K | ★ 1.2M |
| Earning Date | 11-04-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $457,012,000.00 | $129,873,000.00 |
| Revenue This Year | N/A | $101.67 |
| Revenue Next Year | $12.69 | $10.87 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 78.61 |
| 52 Week Low | $0.56 | $1.25 |
| 52 Week High | $1.29 | $5.92 |
| Indicator | PRPL | STIM |
|---|---|---|
| Relative Strength Index (RSI) | 43.10 | 41.10 |
| Support Level | $0.70 | $1.34 |
| Resistance Level | $0.78 | $1.64 |
| Average True Range (ATR) | 0.05 | 0.15 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 16.42 | 23.81 |
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.